Equity Details
Price & Market Data
Price: $7.93
Daily Change: -$0.26 / 3.28%
Daily Range: $7.79 - $8.19
Market Cap: $874,674,432
Daily Volume: 423,894
Performance Metrics
1 Week: -10.90%
1 Month: 14.76%
3 Months: 40.85%
6 Months: 48.22%
1 Year: 48.22%
YTD: 45.50%
About Aura Biosciences, Inc. (AURA)
Discover the market presence of Aura Biosciences, Inc. (AURA). Price: 7.93, daily change: -$0.26 / 3.28%. Market cap: 874,674,432. Performance across all periods for a clear financial view.
Company Details
Employees: 113
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.